UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006348
Receipt number R000007495
Scientific Title Comparative effects of amiodarone vs bisoprolol for postoperative atrial fibrillation
Date of disclosure of the study information 2011/09/20
Last modified on 2015/10/20 22:39:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative effects of amiodarone vs bisoprolol for postoperative atrial fibrillation

Acronym

Comparative effects of amiodarone vs bisoprolol for postoperative atrial fibrillation

Scientific Title

Comparative effects of amiodarone vs bisoprolol for postoperative atrial fibrillation

Scientific Title:Acronym

Comparative effects of amiodarone vs bisoprolol for postoperative atrial fibrillation

Region

Japan


Condition

Condition

valve disease or coronary artery disease with hypertension

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To know whether preoperative administration of beta blocker can supress the new onset of postoperative atrial fibrillation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

new onset of postoperative atrial fibrillation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Take amiodaron 400 mg a day for 7 days preoperatively and resume taking amiodaron 200 mg a day on the first postoperative day

Interventions/Control_2

Take bisoprolol 5 mg a day for 7 days preoperatively and resume taking bisoprolol 5 mg a day on the first postoperative day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

those who has hypertension and going to have cardiac operation such as valve replacement, valve plasty or coronary artery bypass grafting

Key exclusion criteria

low cardiac output, congested heart failure, emergency operation, paroxysmal atrial fibrillation or flutter, PSVT, pacemaker or ICD implant, those who takes group 1 or 3 antiarrhythmic medication, hepatic insufficiency, bradycardia less than HR 50/min, more than second degree atrioventricular block, hemodyalysis patients, those who has beta blocker preoperatively

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ichihara Yuki

Organization

Yamanashi prefectural central hospital

Division name

cardiovascular surgery

Zip code


Address

1-1-1, Fujimi, Kouhu-shi, Yamanashi, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Yamanashi prefectural central hospital

Division name

cardiovascular surgery

Zip code


Address


TEL

055-253-7111

Homepage URL


Email



Sponsor or person

Institute

Yamanashi prefectural central hospital

Institute

Department

Personal name



Funding Source

Organization

Yamanashi prefectural central hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 09 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 10 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 09 Month 14 Day

Last modified on

2015 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007495


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name